The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain

Biomaterials

Volumn 32, Issue 3, 2011, Pages 899-908

  Jin, Yin Chuan ^a   Kim, Seung Woo ^a   Cheng, Felice ^b   Shin, Joo Hyun ^a   Park, Jin Kuen ^b   Lee, Sanghyun ^c   Lee, Jung Eun ^d   Han, Pyung Lim ^d   Lee, Minhyung ^c   Kim, Kyekyoon Kevin ^b   Choi, Hyungsoo ^b   Lee, Ja Kyeong ^a  

^a Inha University School of Medicine   (South Korea)

^b University of Illinois at Urbana Champaign   (United States)

^c Hanyang University   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

A box; Brain ischemia; Gelatin microsphere; HMGB1; MCAO; Neuroprotection

Indexed keywords

A BOX; BRAIN ISCHEMIA; GELATIN MICROSPHERES; HMGB1; MCAO; NEUROPROTECTION;

MICROSPHERES; PEPTIDES;

BRAIN;

BRAIN PROTEIN; GELATIN; MICROSPHERE; PROTEIN HMGB1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN SIZE; DRUG EFFECT; IN VIVO STUDY; MOLECULE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN; DRUG CARRIERS; GELATIN; HMGB1 PROTEIN; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROSPHERES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MURINAE; RATTUS;

EID: 78549260320     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.054     Document Type: Article

References (38)

1. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007, 220:35-46.
2. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
3. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
4. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
5. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003, 22:5551-5560.
6. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126:389-392.
7. Agnello D., Wang H., Yang H., Tracey K.J., Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002, 18:231-236.
8. Kim J.B., Choi J.S., Yu Y.M., Nam K., Piao C.S., Kim S.W., et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006, 26:6413-6421.
9. Kim I.D., Lim C.M., Kim J.B., Nam H.Y., Nam K., Kim S.W., et al. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J Control Release 2010, 142:422-430.
10. Weir H.M., Kraulis P.J., Hill C.S., Raine A.R., Laue E.D., Thomas J.O. Structure of the HMG box motif in the B-domain of HMG1. EMBO J 1993, 12:1311-1319.
11. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 2003, 9:37-45.
12. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004, 173:307-313.
13. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301.
14. Yuan H., Jin X., Sun J., Li F., Feng Q., Zhang C., et al. Protective effect of HMGB1 a box on organ injury of acute pancreatitis in mice. Pancreas 2009, 38:143-148.
15. Gong Q., Xu J.F., Yin H., Liu S.F., Duan L.H., Bian Z.L. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol 2009, 69:29-35.
16. Brime B., Ballesteros M.P., Frutos P. Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration. J Microencapsul 2000, 17:777-784.
17. Leucuta S.E., Ponchel G., Duchene D. Oxprenolol release from bioadhesive gelatin/poly(acrylic acid) microspheres. J Microencapsul 1997, 14:511-522.
18. Wang J., Tabata Y., Bi D., Morimoto K. Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. J Control Release 2001, 73:223-231.
19. Nakase H., Okazaki K., Tabata Y., Ozeki M., Watanabe N., Ohana M., et al. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease. J Pharmacol Exp Ther 2002, 301:59-65.
20. Ikada Y., Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998, 31:287-301.
21. Barbetta A., Dentini M., Zannoni E.M., De Stefano M.E. Tailoring the porosity and morphology of gelatin-methacrylate polyHIPE scaffolds for tissue engineering applications. Langmuir 2005, 21:12333-12341.
22. Kempen D.H., Lu L., Hefferan T.E., Creemers L.B., Maran A., Classic K.L., et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29:3245-3252.
23. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30:2816-2825.
24. Kimura Y., Tsuji W., Yamashiro H., Toi M., Inamoto T., Tabata Y. In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. J Tissue Eng Regen Med 2010, 4:55-61.
25. Lin X., Jo H., Ishii T.M., Fujita M., Fu M., Tambara K., et al. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J 2009, 73:2315-2321.
26. Han Y., Wei Y., Wang S., Song Y. Cartilage regeneration using adipose-derived stem cells and the controlled-released hybrid microspheres. Joint Bone Spine 2010, 77:27-31.
27. Choy Y.B., Choi H., Kim K.K. Uniform biodegradable hydrogel microspheres fabricated by a surfactant-free electric-field-assisted method. Macromol Biosci 2007, 7:423-428.
28. Choy Y.B., Cheng F., Choi H., Kim K.K. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density. Macromol Biosci 2008, 8:758-765.
29. Han J.S., Kim K., Lee M. A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J Cell Biochem 2009, 107:163-170.
30. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
31. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996, 224:855-862.
32. Lalancette-Hébert M., Gowing G., Simard A., Weng Y.C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605.
33. Kokkola R., Li J., Sundberg E., Aveberger A.C., Palmblad K., Yang H., et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003, 48:2052-2058.
34. Sitia G., Iannacone M., Muller S., Bianchi M.E., Guidotti L.G. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol 2007, 81:100-107.
35. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008, 28:12023-12031.
36. Candelario-Jalil E., Yang Y., Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994.
37. Rosenberg G.A., Estrada E.Y., Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195.
38. Kawai K., Suzuki S., Tabata Y., Ikada Y., Nishimura Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 2000, 21:489-499.